Genotypes and Haplotypes in the AXIN2 and TCF7L2 Genes are Associated With Susceptibility and With Clinicopathological Characteristics in Breast Cancer Patients.
M A Rosales-Reynoso, V Rosas-Enríquez, A M Saucedo-Sariñana, M Pérez-Coria, M P Gallegos-Arreola, E Salas-González, P Barros-Núñez, C I Juárez-Vázquez, S E Flores-Martínez, J Sánchez-Corona
{"title":"Genotypes and Haplotypes in the <i>AXIN2</i> and <i>TCF7L2</i> Genes are Associated With Susceptibility and With Clinicopathological Characteristics in Breast Cancer Patients.","authors":"M A Rosales-Reynoso, V Rosas-Enríquez, A M Saucedo-Sariñana, M Pérez-Coria, M P Gallegos-Arreola, E Salas-González, P Barros-Núñez, C I Juárez-Vázquez, S E Flores-Martínez, J Sánchez-Corona","doi":"10.3389/bjbs.2021.10211","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Breast cancer is a multifactorial disease whose genetic susceptibility is related to polymorphic variants of cell proliferation and migration pathways. Variants in <i>AXIN2</i> and <i>TCF7L2</i> in the Wnt-β catenin pathway have been associated with different types of cancer; however, little is known about its role in breast cancer. This study tests the hypothesis of links between <i>AXIN2</i> rs1133683 and rs2240308, and <i>TCF7L2</i> rs7903146 and rs12255372 variants in breast cancer. <b>Methods:</b> Peripheral blood samples were obtained from 404 women (202 patients and 202 control females). The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methodology was used to identify the gene variants. <b>Results:</b> The <i>AXIN2</i> rs2240308 (C > T), and <i>TCF7L2</i> rs7903146 (C > T) and rs12255372 (G > T) variants were associated with breast cancer and with age, TNM stage, and histologic-molecular subtype (<i>p</i> = 0.001). Likewise, the haplotype T-T in the <i>TCF7L2</i> gene (rs7903146-rs12253372) was significantly related with breast cancer (OR = 2.66, 95%, CI = 1.64-4.30, <i>p</i> = 0.001). <b>Conclusion:</b> Our data show a link between <i>AXIN2</i> rs2240308 and <i>TCF7L2</i> rs7903146 and rs12255372 variants in breast cancer, and speculate this may be important in pathogenesis.</p>","PeriodicalId":9236,"journal":{"name":"British Journal of Biomedical Science","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2022-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915722/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Biomedical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/bjbs.2021.10211","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Breast cancer is a multifactorial disease whose genetic susceptibility is related to polymorphic variants of cell proliferation and migration pathways. Variants in AXIN2 and TCF7L2 in the Wnt-β catenin pathway have been associated with different types of cancer; however, little is known about its role in breast cancer. This study tests the hypothesis of links between AXIN2 rs1133683 and rs2240308, and TCF7L2 rs7903146 and rs12255372 variants in breast cancer. Methods: Peripheral blood samples were obtained from 404 women (202 patients and 202 control females). The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methodology was used to identify the gene variants. Results: The AXIN2 rs2240308 (C > T), and TCF7L2 rs7903146 (C > T) and rs12255372 (G > T) variants were associated with breast cancer and with age, TNM stage, and histologic-molecular subtype (p = 0.001). Likewise, the haplotype T-T in the TCF7L2 gene (rs7903146-rs12253372) was significantly related with breast cancer (OR = 2.66, 95%, CI = 1.64-4.30, p = 0.001). Conclusion: Our data show a link between AXIN2 rs2240308 and TCF7L2 rs7903146 and rs12255372 variants in breast cancer, and speculate this may be important in pathogenesis.
期刊介绍:
The British Journal of Biomedical Science is committed to publishing high quality original research that represents a clear advance in the practice of biomedical science, and reviews that summarise recent advances in the field of biomedical science. The overall aim of the Journal is to provide a platform for the dissemination of new and innovative information on the diagnosis and management of disease that is valuable to the practicing laboratory scientist.